Metlifecare (ASX:MEQ) ROE % Adjusted to Book Value: 0.00% (As of Jun. 2020)


What is Metlifecare ROE % Adjusted to Book Value?

Metlifecare ASX:MEQ 4 ROE % Adjusted to Book Value is 0.00% as of Jun. 2020. GuruFocus rates ASX:MEQ with a GF Score™ of 4/100. The stock has 8 warning signs investors should review.

Metlifecare's ROE % for the quarter that ended in Jun. 2020 was -7.60%. Metlifecare's PB Ratio for the quarter that ended in Jun. 2020 was N/A. Metlifecare's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2020 was N/A.

Metlifecare ROE % Adjusted to Book Value Related Terms

Metlifecare ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Metlifecare's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Metlifecare ROE % Adjusted to Book Value Chart

Metlifecare Annual Data
Trend Jun11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Metlifecare Semi-Annual Data
Dec10 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ASX:MEQ vs HCA, DVA, UHS: ROE % Adjusted to Book Value Comparison

For the Medical Care Facilities subindustry, Metlifecare's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Metlifecare ROE % Adjusted to Book Value vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Metlifecare's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Metlifecare's ROE % Adjusted to Book Value falls into.


Metlifecare ROE % Adjusted to Book Value Calculation

Metlifecare's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2020 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-2.21% / N/A
=N/A

Metlifecare's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2020 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-7.60% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 0.00% mean?
Metlifecare (ASX:MEQ) has a ROE % Adjusted to Book Value of 0.00% as of Jun. 2020. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Metlifecare and its competitors.
Is Metlifecare's ROE % Adjusted to Book Value too high?
Metlifecare's current ROE % Adjusted to Book Value is 0.00%. Overall, Metlifecare has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Metlifecare's ROE % Adjusted to Book Value compare to HCA and DVA?
Metlifecare's ROE % Adjusted to Book Value of 0.00% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Healthcare Providers & Services company?
A good ROE % Adjusted to Book Value depends on the Healthcare Providers & Services industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Metlifecare and its competitors. Metlifecare's current ROE % Adjusted to Book Value is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Metlifecare stock overvalued right now?
Metlifecare (ASX:MEQ) has a current ROE % Adjusted to Book Value of 0.00%. The current ROE % Adjusted to Book Value is 0.00%. Metlifecare's overall GF Score™ is 4/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Metlifecare (ASX:MEQ), the current ROE % Adjusted to Book Value is 0.00% as of Jun. 2020. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Metlifecare Business Description

Address 20 Kent Street, Level 4, Newmarket, Auckland, NTL, NZL, 1023
Metlifecare Ltd operates retirement communities throughout New Zealand. It generates revenue from membership fees and rest home, hospital and service, and village fees. Metlifecare's membership fees are paid by residents of independent living units and serviced apartments and allow residents to use common facilities. Its largest single customer is the New Zealand government, which pays fees on behalf of residents eligible for government subsidized elderly care. The majority of Metlifecare's retirement villages are located in Auckland.